Your browser doesn't support javascript.
loading
Predicting Antiviral Resistance Mutations in SARS-CoV-2 Main Protease with Computational and Experimental Screening.
Sasi, Vishnu M; Ullrich, Sven; Ton, Jennifer; Fry, Sarah E; Johansen-Leete, Jason; Payne, Richard J; Nitsche, Christoph; Jackson, Colin J.
Afiliação
  • Sasi VM; Research School of Chemistry, Australian National University, Canberra ACT 2601, Australia.
  • Ullrich S; Research School of Chemistry, Australian National University, Canberra ACT 2601, Australia.
  • Ton J; Research School of Chemistry, Australian National University, Canberra ACT 2601, Australia.
  • Fry SE; School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia.
  • Johansen-Leete J; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney NSW 2006, Australia.
  • Payne RJ; School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia.
  • Nitsche C; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney NSW 2006, Australia.
  • Jackson CJ; School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia.
Biochemistry ; 61(22): 2495-2505, 2022 11 15.
Article em En | MEDLINE | ID: mdl-36326185
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Inibidores de Proteases / Farmacorresistência Viral / Proteases 3C de Coronavírus / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Biochemistry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Inibidores de Proteases / Farmacorresistência Viral / Proteases 3C de Coronavírus / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Biochemistry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália